The Hidden Science of
Amino Acid Absorption
— and Why Most Supplements Fail
A landmark ERCC clinical study reveals that what you digest matters far less than what your body can actually absorb — and that AstraZyme® changes the equation entirely.
Every protein you eat — whether from a steak, a smoothie, or a supplement — must be broken down into peptides and amino acids before your body can use any of it. But here's the uncomfortable truth that most supplement labels quietly ignore: digestion and absorption are two completely different things. You can digest protein perfectly and still absorb only a fraction of the available amino acids.
This distinction is at the heart of a rigorous clinical study conducted by the Enzymology Research Center Catalysts, Inc. (ERCC) — and its findings are striking enough to reshape how we think about gut health supplements entirely.
"AstraZyme® can not only effectively breakdown proteins but also increase the bioavailability and absorption of peptides and amino acids in human intestinal cells."
— ERCC AstraZyme® Study, Enzymology Research Center Catalysts, Inc.What Is AstraZyme® — and Why Does It Matter?
AstraZyme® is a proprietary, clinically validated combination of two distinct components that work in concert to close the gap between digestion and absorption:
ERCC1™ — Proteolytic Enzyme Blend
A proprietary blend of proteolytic enzymes with trace minerals that breaks down proteins — including hemoglobin, whey, and collagen — into absorbable peptides and amino acids. Works across a wide pH range of 4.0–10.0, mirroring the full human digestive tract from stomach to small intestine.
AstraGin® — Botanical Absorption Enhancer
Derived from extracts of Astragalus membranaceus and Panax notoginseng, AstraGin® has been validated in multiple in vitro and in vivo studies to enhance cellular uptake of amino acids, vitamins, and glucose by up-regulating mRNA and carrier transport proteins in the small intestine.
Together, they address the two-stage challenge of nutrition: first, breaking large proteins into small enough units to cross the intestinal wall; second, actively transporting those units into the bloodstream at a significantly higher rate and quantity.
The Study: Rigorous, Reproducible Science
The ERCC study used human small intestinal Caco-2 cell monolayers — the gold standard model for intestinal absorption research, widely accepted as a physiologically accurate proxy for human gut transport. The model tests whether substances actually cross the intestinal barrier, not merely whether they dissolve in gut fluid.
Part 1: Protein Digestion — The Foundation
Before any absorption can occur, proteins must be hydrolyzed into smaller fragments. The study tested ERCC1™'s ability to digest bovine hemoglobin across a wide range of pH values — critically important because the human digestive tract spans from highly acidic (stomach, pH ~2) to neutral and slightly alkaline (small intestine, pH 7–8).
Key finding: ERCC1™ digested over 90% of bovine hemoglobin across all tested pH values (4, 6, 8, and 10), demonstrating robust activity that mirrors the full range of the human digestive tract. Without ERCC1™, hemoglobin remained 100% undigested and completely unavailable for absorption.
Time-Course Finding
In a separate time-course experiment at pH4, ERCC1™ hydrolyzed 87.8% of hemoglobin within just 30 minutes, reaching >95% digestion by 60 minutes, with maximum efficacy plateau at 90 minutes. Digestion was rapid, progressive, and reproducible.
Part 2: The Absorption Gap — Quantity
Protein digestion is necessary — but not sufficient. The critical question is: how much of those liberated amino acids actually cross the intestinal wall and enter the bloodstream? This is where AstraGin® demonstrates its most dramatic effect.
Key finding: When AstraGin® was added at 1X strength, total amino acid absorption increased by 70% over enzyme-only (100% → 170%). At 10X strength, the increase reached 125% (100% → 225%). Without ERCC1™, virtually no amino acids were absorbed at all — confirming that digestion must precede absorption.
Part 3: The Absorption Gap — Speed
Quantity absorbed is only half the picture. The rate of absorption — how fast amino acids enter the bloodstream — determines how quickly your muscles, organs, and immune system can benefit. Post-workout recovery, protein synthesis timing, and metabolic efficiency all depend on this number.
Key finding: AstraGin® at 1X dose increased the rate of amino acid transport by 61% in the first 15 minutes. At 10X, the rate more than doubled (+110%). This means nutrients don't just get absorbed in greater quantities — they enter the bloodstream significantly faster, maximizing the post-meal metabolic window.
The Complete Picture: Peptides & Amino Acids
The study also demonstrated AstraGin®'s effect on peptide absorption — the critical intermediate stage between whole proteins and free amino acids. The pattern across every measurement is consistent and dose-dependent:
| Measurement | No Enzyme | ERCC1™ Only | +AstraGin® 1X | +AstraGin® 10X |
|---|---|---|---|---|
| Peptide transport rate (45 min) | <1% | 100% | +30% | +66% |
| Total peptides absorbed (AUC) | <1% | 100% | +41% | +83% |
| Amino acid transport rate (15 min) | <1% | 100% | +61% | +110% |
| Total amino acids absorbed (AUC) | <1% | 100% | +70% | +125% |
Critically, without ERCC1™ to break proteins down first, essentially nothing was absorbed at any level — confirming that AstraGin® enhances transport, not digestion itself. The two components are synergistic, not redundant.
What This Means for Your Gut Health
The implications of this research extend far beyond athletic performance or protein supplementation. Amino acids are the raw material for neurotransmitters, immune cells, hormones, enzymes, and structural proteins across every tissue in the body. When absorption is impaired — by poor enzyme activity, gut inflammation, or barrier dysfunction — the downstream effects touch everything from mood and energy to immune resilience and muscle maintenance.
"Gut health is not just about digestion — it's the gateway to systemic health. Every nutrient your body depends on must pass through the intestinal barrier to reach the cells that need it."
— Integrated view of GI and systemic nutrition scienceWho Benefits Most from AstraZyme® Support?
People with candida overgrowth or chronic gut imbalance (impaired enzyme secretion), those experiencing bloating after protein-rich meals (incomplete digestion), anyone over 40 (natural enzyme decline with age), athletes seeking faster recovery, and individuals on elimination diets with high protein needs — all stand to benefit meaningfully from enhanced enzymatic digestion and absorption.
The PureCandida Digestive Enzyme supplement incorporates AstraZyme® as its core bioavailability technology, paired with 18 additional digestive enzymes and probiotics to create comprehensive gut support that goes beyond simple digestion — ensuring the nutrients you consume are actually delivered to the cells that need them.
5 Key Takeaways from the ERCC Research
Digestion ≠ Absorption
You can digest 90%+ of a protein and still absorb only a fraction of amino acids. The intestinal barrier step is the real bottleneck — and it's largely ignored by standard supplements.
ERCC1™ Works Across Your Entire Gut
With >90% protein hydrolysis maintained from pH 4 to pH 10, ERCC1™ functions reliably in both the acidic stomach and the neutral small intestine — unlike single-enzyme products that fail outside narrow pH windows.
AstraGin® Is an Absorption Amplifier, Not a Digestion Aid
AstraGin® had zero effect on ERCC1™ enzyme activity — its mechanism is entirely separate, operating at the intestinal transport protein level. The two components complement without interfering with each other.
The Gains Are Statistically Significant and Dose-Dependent
All improvements (p<0.01 or p<0.05) were statistically significant vs. controls, and consistently larger at 10X vs. 1X AstraGin® doses — indicating a genuine, reliable, scalable biological effect.
Speed Matters as Much as Quantity
A 61% increase in transport rate means amino acids are available for muscle repair, immune function, and neurotransmitter synthesis faster — maximizing the metabolic window when timing matters most.
Research Sources
Primary Study: "AstraZyme® Study" — Enzymology Research Center Catalysts, Inc. (ERCC), 215 Main Street, Miltona, MN 56354. Conducted using human small intestinal Caco-2 cell monolayer model. Statistical threshold: p<0.05 (*) and p<0.01 (**).
Supporting Material: AstraZyme® Full Spectrum Enzymes Product Sheet — STAUBER / ERCC, 4120 N. Palm Street, Fullerton, CA 92835.
These statements have not been evaluated by the Food and Drug Administration. This content is for educational purposes only and does not constitute medical advice. AstraGin® is a registered trademark of NuLiv Science USA, Inc. AstraZyme® is a registered trademark of Enzymology Research Center Catalysts, Inc.
